← Leaderboards
Carolyn L Westhoff
Columbia University Health Sciences
$8,326,369
Attributed
$8,326,369
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,326,369 · 9
By mechanism
R01$4,337,732 · 3
N01$3,988,637 · 6
Top collaborators
No co-investigators on record.
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Bruce Levin$4,865,662
- Benjamin Landon Myer$8,501,100
- Sanyukta Mathur$519,489
- Patricia A. Murphy$1,116,612
- Maria J Wawer$20,688,190
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsContraceptive AgentsWomanContraceptive MethodsClinical Trials NetworkNational Institute Of Child Health And Human DevelopmentSafetyFemale Contraceptive AgentsProtocols DocumentationDosePharmaceutical PreparationsBaseContractsDevicesReproductiveGynecologicProtocol DevelopmentDrug CandidateSiteContraceptive EfficacyObesityTreatment TrialFemaleAdvisory Committees
Grant awards (33)
CCTN - PHARMACOKINETIC AND PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION - COLOMBIA$77,294
N01 · FY2024 · HD · contact PI
CCTN - PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$21,924
N01 · FY2023 · HD · contact PI
CCTN - PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$111,167
N01 · FY2021 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: PILOT AND EFFICACY STUDY$6,050
N01 · FY2021 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: PILOT AND EFFICACY STUDY$50,955
N01 · FY2020 · HD · contact PI
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.$291,399
R01 · FY2019 · CA · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - EVALUATION REVERSIBLE CONTRACEPTIVE$290,757
N01 · FY2019 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: PILOT AND EFFICACY STUDY$130,447
N01 · FY2019 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$12,154
N01 · FY2019 · HD · contact PI
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.$406,451
R01 · FY2018 · CA · contact PI
CCTN - PHARMACOKINETIC / PHARMACODYNAMIC EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$301,685
N01 · FY2018 · HD · contact PI
CCTN - NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE)$46,218
N01 · FY2018 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$12,056
N01 · FY2018 · HD · contact PI
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.$494,977
R01 · FY2017 · CA · contact PI
CONTRACEPTIVE EFFICACY EVALUATION OF THE PATH FEMALE CONDOM$21,528
N01 · FY2017 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$11,958
N01 · FY2017 · HD · contact PI
A Prospective, Randomized Study to Compare Effects of Ulipristal Acetate with a Combined Oral Contraceptive on Breast Epithelial Cell Proliferation.$439,302
R01 · FY2016 · CA · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$11,862
N01 · FY2016 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - EVALUATION REVERSIBLE CONTRACEPTIVE$358,353
N01 · FY2015 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$16,854
N01 · FY2015 · HD · contact PI
CCTN - CLINICAL EVALUATION OF NOVEL PRODUCTS FOR FEMALE CONTRACEPTION: PILOT AND EFFICACY STUDY$423,340
N01 · FY2014 · HD · contact PI
CLINICAL EVALUATION OF NESTORONE/ESTRADIOL-RELEASING VAGINAL RING FOR FEMALE CONTRACEPTION$50,009
N01 · FY2014 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$25,390
N01 · FY2014 · HD · contact PI
CLINICAL EVALUATION OF NESTORONE/ESTRADIOL-RELEASING VAGINAL RING FOR FEMALE CON$1,407,813
N01 · FY2011 · HD · contact PI
CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK - CORE - FEMALE$97,872
N01 · FY2011 · HD · contact PI
CCTN-CLINICAL EVALUATION OF LEVONORGESTREL BUTANOATE FOR FEMALE CONTRACEPTION$80,015
N01 · FY2011 · HD · contact PI
NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE)$422,936
N01 · FY2010 · HD · contact PI
Obesity, Oral Contraception and Ovarian Suppression$395,535
R01 · FY2007 · HD · contact PI
Obesity, Oral Contraception and Ovarian Suppression$423,411
R01 · FY2006 · HD · contact PI
Obesity, Oral Contraception and Ovarian Suppression$296,589
R01 · FY2005 · HD
RCT of a Novel Oral Contraceptive Initiation Method$262,653
R01 · FY2004 · HD
RCT of a Novel Oral Contraceptive Initiation Method$674,513
R01 · FY2003 · HD
RCT of a Novel Oral Contraceptive Initiation Method$652,902
R01 · FY2002 · HD